VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹112 Cr | ₹80 Cr | ₹77 Cr | ₹39 Cr | ₹32 Cr |
What is the latest Sundry Debtors ratio of VENUS REMEDIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹112 Cr |
| Mar2024 | ₹80 Cr |
| Mar2023 | ₹77 Cr |
| Mar2022 | ₹39 Cr |
| Mar2021 | ₹32 Cr |
How is Sundry Debtors of VENUS REMEDIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹112 Cr | 39.40 | |
| Mar2024 | ₹80 Cr | 5.01 | |
| Mar2023 | ₹77 Cr | 98.60 | |
| Mar2022 | ₹39 Cr | 20.47 | |
| Mar2021 | ₹32 Cr | - | |
Compare Sundry Debtors of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,299.1 Cr | 12.1% | 38.3% | 194.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,150.0 Cr | -0.9% | -3.9% | 1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,129.0 Cr | -0.4% | -7.6% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,312.0 Cr | -2% | -7.5% | 27.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,445.2 Cr | -1.5% | -9.3% | 3.8% | Stock Analytics | |
| CIPLA | ₹98,210.2 Cr | 1.7% | -8.3% | -16.8% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 12.1% |
38.3% |
194.7% |
| SENSEX | 7.8% |
-2% |
0.2% |
You may also like the below Video Courses